In breast cancer, ZMYND8 was found to interact with HIF-1α and HIF-2α, and it can also recruit of BRD4 and release paused RNA polymerase II to enhance the HIF-induced oncogenicity [32]. Here, EPAS1 is linked to breast carcinoma.